Review
Open access
Sep 2026
p53 Co-mutations in EGFR-mutant NSCLC: biological insight and therapeutic implications.
Non-small cell lung cancer (NSCLC) harbouring mutations in the epidermal growth factor receptor (EGFR) represents a well-defined molecular subset that is amenable to targeted therapies. However, clinical heterogeneity in treatment response and resistance highlights the critical need for a deeper understanding of co-occ...
J. Etessami, I. Attili, P. T. Aliaga et al.
· Cancer Treatment Reviews · 0 citations